Basit öğe kaydını göster

A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

dc.contributor.authorYildiz, Ibrahim
dc.contributor.authorSen, Fatma
dc.contributor.authorAydiner, Adnan
dc.contributor.authorKeskin, Serkan
dc.contributor.authorCiftci, Rumeysa
dc.contributor.authorSerilmez, Murat
dc.contributor.authorTas, Faruk
dc.contributor.authorSaip, Pinar
dc.contributor.authorYasasever, Vildan
dc.contributor.authorEralp, Yesim
dc.contributor.authorKilic, Leyla
dc.contributor.authorKarabulut, Senem
dc.date.accessioned2021-03-05T16:06:39Z
dc.date.available2021-03-05T16:06:39Z
dc.date.issued2013
dc.identifier.citationYildiz I., Tas F., Kilic L., Sen F., Saip P., Eralp Y., Keskin S., Karabulut S., Ciftci R., Serilmez M., et al., "A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer", CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.72, ss.437-444, 2013
dc.identifier.issn0344-5704
dc.identifier.othervv_1032021
dc.identifier.otherav_bf126d33-e74e-4f16-ae33-1019751fbe20
dc.identifier.urihttp://hdl.handle.net/20.500.12627/126876
dc.identifier.urihttps://doi.org/10.1007/s00280-013-2212-z
dc.description.abstractThis study was conducted to determine the clinical significance of serum M30 and M65 in epithelial ovarian cancer (EOC).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectPharmacology (medical)
dc.subjectOncology
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectONKOLOJİ
dc.titleA high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer
dc.typeMakale
dc.relation.journalCANCER CHEMOTHERAPY AND PHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume72
dc.identifier.issue2
dc.identifier.startpage437
dc.identifier.endpage444
dc.contributor.firstauthorID7244


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster